Y.S.P. Southeast Asia Holding Berhad (KLSE: YSPSAH)
Health Care · Pharmaceuticals · MY
RM2.02
-0.49% today · -1.9% 1Y
Y.S.P. Southeast Asia Holding Berhad (KLSE: YSPSAH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $70.95M.
Over the last twelve months the share price has lost 1.9%, trading between 2.01 and 2.20.
Tweenvest scores Y.S.P. Southeast Asia Holding Berhad across four factors: quality 80/100, value 69/100, growth 32/100, dividend 76/100. Its strongest factor is quality.
YSPSAH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $70.95M
- Revenue (TTM)
- $90.48M
- P/E
- 10.61
- EPS
- 0.17
- Dividend yield
- 5.45%
- Beta (5Y)
- -0.00
- 52-week high
- RM2.20
- 52-week low
- RM2.01
- Avg volume (3M)
- —
- Shares outstanding
- 141.84M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.